Emergencies: Clinical Trials

4 trials for Emergencies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Recruiting 4

Follow Emergencies: new trials by email Literature Review of Emergencies trials Research Report on Emergencies

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Bundled Intervention to End Opioid Overdoses
Bundled intervention (Experimental), control group, Buprenorphine (Experimental) - Opioid Use Disorder, Opioid Overdose
Phase 4RecruitingUniversity of Alabama at Birmingham1602026-09-072026-10-02
45th Multicenter Airway Research Collaboration
Airsupra - Asthma Acute, Asthma Exacerbation
Phase 4RecruitingMassachusetts General Hospital18602025-11-072026-04-17
Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department
Prednisone, Dexamethasone, Placebo - Osteoarthritis, Osteoarthritis (OA) of the Knee
Phase 4RecruitingWellSpan Health1922025-02-242026-08-19
Trigger Point Injection for Myofascial Pain Syndrome in the Low Back: A Randomized Controlled Trial
Treatment of Myofascial Pain Syndrome in the low back. This intervention will be based on outcomes of the medications listed below., Evaluation of functional ability using a patient centered functional score known as the Modified Oswestry Disability Index (MODI). The intervention will be based on outcomes of medications below., Following up with participants 60-72 hours after treatment in the Emergency Department. This intervention will be based on outcomes of the medications listed below. - Low Back Pain, Myofascial Pain Syndrome Lower Back
Phase 4RecruitingMadigan Army Medical Center1802020-12-282021-01-12

Narrower conditions

Acute Pain (1)  ·  Asthma (1)  ·  Low Back Pain (1)  ·  Myofascial Pain Syndromes (1)  ·  Opiate Overdose (1)  ·  Opioid-Related Disorders (1)  ·  Osteoarthritis (1)

Broader conditions

Disease Attributes (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Musculoskeletal Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pain (2)  ·  Signs and Symptoms (2)  ·  Arthritis (1)  ·  Back Pain (1)  ·  Bronchial Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Drug Misuse (1)  ·  Drug Overdose (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)

Interventions

Acetaminophen (1)  ·  Aftercare (1)  ·  Bupivacaine (1)  ·  Buprenorphine (1)  ·  Control Groups (1)  ·  Dexamethasone (1)  ·  Ibuprofen (1)  ·  Ketorolac (1)  ·  Prednisone (1)  ·  Saline Solution (1)  ·  cyclobenzaprine (1)

Sponsors

Madigan Army Medical Center (1)  ·  Massachusetts General Hospital (1)  ·  University of Alabama at Birmingham (1)  ·  WellSpan Health (1)

Countries

United States (4)

Top investigators

Brent Becker, MD (1)  ·  Joshua J Oliver, MD (1)  ·  Li Li, MD;PhD (1)

NIH funding

R33DA062351 (1)